Details for New Drug Application (NDA): 203455
✉ Email this page to a colleague
The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Summary for 203455
Tradename: | NADOLOL |
Applicant: | Invagen Pharms |
Ingredient: | nadolol |
Patents: | 0 |
Pharmacology for NDA: 203455
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 203455
Suppliers and Packaging for NDA: 203455
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NADOLOL | nadolol | TABLET;ORAL | 203455 | ANDA | Major Pharmaceuticals | 0904-7070 | 0904-7070-07 | 30 BLISTER PACK in 1 CARTON (0904-7070-07) / 1 TABLET in 1 BLISTER PACK |
NADOLOL | nadolol | TABLET;ORAL | 203455 | ANDA | Major Pharmaceuticals | 0904-7070 | 0904-7070-61 | 100 BLISTER PACK in 1 CARTON (0904-7070-61) / 1 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Dec 18, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Dec 18, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Dec 18, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription